Ipca Laboratories Ltd has informed BSE that it has received USFDA approval for its oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur, Madhya Pradesh.
This approval will enable the company to commercialise more oral solid dosage formulations in the US market.
Its stocks were trading 5% higher at Rs 392 apiece on BSE at 1330 hours.
